04 - 05 November 2021 | London, UK

Yann Abraham

Computational Immunologist
Janssen
Yann Abraham
As part of the Discovery Science department of Janssen Pharmaceutica, Yann has been working on the application of mass cytometry to clinical trials, building high dimensional analysis and visualization solutions to gain insights into disease mechanisms and response to treatment. Before joining Janssen Pharmaceutica, he worked on target identification and target validation using transcriptomics and mass spectrometry, blending biology, technology and analysis. Yann received his PhD in biochemistry from the Universite Paris XI Orsay, working on the regulation of centrosome duplication

Sessions

No data was found

Live Webinar

Pitfalls & Best Practices For CRISPR/Cas9-based Gene Editing

hosted by
DR. BENJAMIN SCHMID, Research Scientist, Cellular Engineering and Disease Models, Bioneer A/S
& DR. PETER MOURITZEN, VP Application and Market Development, Samplix ApS